Intrinsic Value of S&P & Nasdaq Contact Us

STERIS plc STE NYSE

NYSE • Healthcare • Medical - Devices • IE • USD

SharesGrow Score
76/100
4/7 Pass
SharesGrow Intrinsic Value
$221.37
-1.5%
Analyst Price Target
$256.67
+14.2%

STERIS plc (STE) — Analyst outlook / Analyst consensus target is. Based on 13 analyst ratings, the consensus is bullish — 11 Buy, 2 Hold.

The consensus price target is $256.67 (low: $245.00, high: $265.00), representing an upside of 14.2% from the current price $224.83.

Analysts estimate Earnings Per Share (EPS) of $5.68 and revenue of $5.24B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $3.83 vs est $5.68 (missed -32.5%). 2025: actual $6.20 vs est $9.10 (missed -31.9%). Analyst accuracy: 53%.

STE Stock — 12-Month Price Forecast

$256.67
▲ +14.16% Upside
Average Price Target
Based on 13 Wall Street analysts offering 12-month price targets for STERIS plc, the average price target is $256.67, with a high forecast of $265.00, and a low forecast of $245.00.
The average price target represents a +14.16% change from the last price of $224.83.
Highest Price Target
$265.00
Average Price Target
$256.67
Lowest Price Target
$245.00

STE Analyst Ratings

Buy
13
Ratings
11 Buy
2 Hold
Based on 13 analysts giving stock ratings to STERIS plc in the past 3 months
Rating breakdown
Buy
11 85%
Hold
2 15%
85%
Buy
11 analysts
15%
Hold
2 analysts
0%
Sell
0 analysts

EPS Estimates — STE

53%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $3.83 vs Est $5.68 ▼ 48.2% off
2025 Actual $6.20 vs Est $9.10 ▼ 46.8% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is improving.

Revenue Estimates — STE

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $5.139B vs Est $5.235B ▼ 1.9% off
2025 Actual $5.460B vs Est $5.450B ▲ 0.2% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message